$PFGC

Why is Performance Food Group stock sliding today?

Performance Food Group (PFGC) shares fell about 4.5% in pre-open trading after the company reported fiscal Q4 2026 results. Earnings were $1.59 per share, slightly below the $1.60 consensus, and revenue was $18.0 billion versus $18.07 billion expected, according to Investing.com. The article also cites prior estimate declines and CEO George L. Holm selling shares.

Original reporting
Published Aug 12, 2026, 12:21 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 12:58 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$PFGC
Bearish
medium confidence
Mentioned
$PFGC
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$PFGCBearishMed
01

Why it matters

A narrow EPS and revenue miss landed after a negative revision trend, producing a sharper-than-market reaction for a thin-margin distributor; the CEO’s late-July sale adds incremental negative optics.

02

Market read

Traders can use the reported EPS and revenue shortfalls versus consensus, plus the negative revision trend, to reassess near-term expectations and risk for PFGC.

03

What to watch

The article does not include management guidance, margin commentary, or segment performance, which could be the real driver behind whether the move extends beyond pre-market.

Relevance 7/10Novelty 6/10Timing: pre-open trading today

Background

The stock was near its 52-week high ($117.47) before the fiscal Q4 print, and analyst EPS estimates had been drifting lower over the prior 90 days.

Company-level read

Ticker impact

$PFGCBearishMedium confidence
Context

Performance Food Group shares slid 4.5% pre-open after fiscal Q4 EPS of $1.59 missed $1.60 consensus and revenue of $18.0B trailed $18.07B.

Expected impact

Bearish near-term bias, with downside risk if the market treats the miss as a margin or demand signal rather than a one-off.

Evidence & confidence

The text provides specific reported figures versus consensus, notes 10 negative EPS revisions vs 1 positive over 90 days, and highlights a CEO sale shortly before results, all consistent with incremental negative sentiment driving the pre-market move.

Market effects

Reinforces that thin-margin food distribution can react sharply to small EPS and revenue misses.

Limited, as the catalyst is company-specific rather than macro-driven.

Low, primarily a US-listed single-name earnings reaction.

Counterpoint

The miss is small (EPS 1 cent, revenue slightly below forecast), so the selloff may be sentiment-driven and could mean-revert if guidance or margins stabilize.

Key entities

  • Performance Food Group

    Foodservice and specialty food distributor whose fiscal Q4 results missed consensus and triggered a pre-market selloff.

  • George L. Holm

    CEO who sold about 29,131 shares on July 30, 2026, reducing his stake by about 2%.

Related articles

$PFGCHigh

Performance Food Group Co (PFGC): Results of Operations and Financial Condition

Performance Food Group Co (PFGC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 pfgc-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE For Immediate Release Investors: Media: William S. Marshall Scott Golden SVP, Investor Relations Director, Communications & Engagement (804) 287-8108 (804) 484-7873 Bill.Marshall@pfgc.com Scott.Golden@pfgc.com Pe

$CAVAMedAI 8/10

CAVA's Biggest Growth Driver Isn't Higher Prices

CAVA Group (NYSE:CAVA) gained 11.38% premarket after reporting Q2 diluted EPS of $0.19 on revenue of $368.4M, above consensus of $0.18 and $360.09M. Same-restaurant sales rose 9.0%, with 5.3% from guest traffic. Net income was $23.0M; adjusted EBITDA rose 30% to $54.7M. Restaurant margin fell to 25.7%. CAVA reaffirmed FY guidance: same-restaurant sales 4.5% to 6.5%, 75 to 77 net new restaurants, and adjusted EBITDA $181M to $191M.

$APREMed

Aprea Therapeutics, Inc. (APRE): Results of Operations and Financial Condition

Aprea Therapeutics, Inc. (APRE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 apre-20260812xex99d1.htm EX-99.1 ​ Exhibit 99.1 ​ Aprea Therapeutics Announces Second Quarter 2026 Financial Results ​ Enrollment in the ongoing Phase 1 dose escalation ACESOT-1051 trial of oral WEE1 inhibitor APR-1051 is accelerating as dose escalation advances Aprea p

Why is Performance Food Group stock sliding today? — alphai